Humira

E697096

Humira is a widely used biologic medication (adalimumab) that treats various autoimmune diseases such as rheumatoid arthritis, psoriasis, and Crohn’s disease by inhibiting tumor necrosis factor (TNF).

All labels observed (4)

Label Occurrences
Humira canonical 2
TNF-alpha inhibitors 1
adalimumab 1

How this entity was disambiguated

Statements (48)

Predicate Object
instanceOf biologic medication ⓘ
monoclonal antibody ⓘ
tumor necrosis factor inhibitor ⓘ
approvalBy European Medicines Agency ⓘ
U.S. Food and Drug Administration ⓘ
approvalYear 2002 ⓘ
bindsTo membrane-bound TNF-alpha ⓘ
soluble TNF-alpha ⓘ
blackBoxWarning malignancy ⓘ
serious infections ⓘ
commonAdverseEffect headache ⓘ
injection site reaction ⓘ
upper respiratory tract infection ⓘ
contraindication active serious infection ⓘ
moderate to severe heart failure ⓘ
developer AbbVie ⓘ
hasATCCode L04AB04 ⓘ
hasDosageForm pre-filled pen ⓘ
pre-filled syringe ⓘ
hasDrugClass TNF-alpha inhibitor ⓘ
immunosuppressive agent ⓘ
hasGenericName adalimumab ⓘ
hasINN adalimumab ⓘ
hasRouteOfAdministration subcutaneous injection ⓘ
indication Crohn's disease ⓘ
ankylosing spondylitis ⓘ
hidradenitis suppurativa ⓘ
juvenile idiopathic arthritis ⓘ
non-infectious intermediate uveitis ⓘ
non-infectious panuveitis ⓘ
non-infectious posterior uveitis ⓘ
plaque psoriasis ⓘ
psoriatic arthritis ⓘ
rheumatoid arthritis ⓘ
ulcerative colitis ⓘ
uveitis ⓘ
isAdministeredBy patient self-injection ⓘ
isBiologic true ⓘ
isBiosimilarAvailable true ⓘ
mechanismOfAction binds to TNF-alpha and blocks its interaction with TNF receptors ⓘ
molecularType recombinant human IgG1 monoclonal antibody ⓘ
originalDeveloper Abbott Laboratories ⓘ
pregnancyCategoryUS B ⓘ
reduces inflammatory response mediated by TNF-alpha ⓘ
requiresMonitoring hepatitis B reactivation ⓘ
signs of infection ⓘ
tuberculosis ⓘ
targets tumor necrosis factor alpha ⓘ

How these facts were elicited

Referenced by (5)

Full triples — surface form annotated when it differs from this entity's canonical label.

AbbVie → notableProduct → Humira ⓘ
Behçet's disease → treatedWith → TNF-alpha inhibitors ⓘ
linked to: Humira
tumor necrosis factor alpha → therapeuticTargetOf → adalimumab ⓘ
linked to: Humira
tumor necrosis factor alpha → therapeuticTargetOf → golimumab ⓘ
linked to: Humira